Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nuclear protein localization protein 4 cofactor–valosin-containing protein segregase complex is a multi-protein assembly central to eukaryotic cellular proteostasis. The core consists of valosin-containing protein (VCP), also known as p97—a highly conserved AAA+ ATPase—and its major adaptors/cofactors NPLOC4 (nuclear protein localization homolog) and UFD1L. This ternary “segregase” uses energy from ATP hydrolysis to extract ubiquitinated substrates from membranes, chromatin, ribosomes, or large macromolecular assemblies so they can be degraded by the proteasome. The process is essential for endoplasmic reticulum-associated degradation (ERAD), mitochondrial quality control, DNA replication/repair regulation during cell cycle progression, membrane fusion events after mitosis, and more. Dysfunctional activity—whether through mutation or pharmacologic inhibition—can result in severe pathologies including neurodegeneration and cancer susceptibility/resistance due to altered clearance capacity for misfolded/damaged proteins.[1][2][3][5]
Disulfiram/CuET: - Induces clustering/aggregation of NPL4, leading to dysfunction of the VCP/p97 segregase pathway. - Causes accumulation of polyubiquitinated proteins due to impaired extraction/degradation. - Results in proteotoxic stress selectively toxic to cancer cells with high proteasome dependency.[3] Other potential mechanisms: - Inhibition or modulation of ATP hydrolysis or adaptor binding could disrupt substrate processing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear protein localization protein 4 cofactor–valosin-containing protein segregase complex (NPL4–p97/VCP segregase complex).